AFTER THIS FALL'S firestorm over the initial conflicts-of-interest document released with the ACCME's new Standards for Commercial Support, I have a deep appreciation for both the difficulties and the benefits of using faculty with ties to pharma. But what about those other conflicts of interest that don't often get talked about? For example, I was speaking with a scientific affairs manager at a large pharma company who went into a bit of a rant about physicians who basically try to extort ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the Beware the Squids!, you'll also gain access to exclusive premium content.

Already registered? here.